🇺🇸 FDA
Pipeline program

Mitapivat

OZUHN-025

Phase 2 small_molecule active

Quick answer

Mitapivat for Anemia is a Phase 2 program (small_molecule) at Agios Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Agios Netherlands B.V.
Indication
Anemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials